TOT BIOPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
TOT BIOPHARM-B: POLL RESULTS OF THE ADJOURNED ANNUAL GENERAL MEETING HELD ON 26 JUNE 2024
TOT BIOPHARM-B: NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED SHAREHOLDERS
TOT BIOPHARM-B: NOTIFICATION LETTER AND REQUEST FORM FOR REGISTERED SHAREHOLDERS
TOT BIOPHARM-B: THIRD FORM OF PROXY
TOT BIOPHARM-B: FURTHER SUPPLEMENTAL NOTICE OF ADJOURNED ANNUAL GENERAL MEETING
TOT BIOPHARM-B: ADDITIONAL PROPOSAL FOR RE-ELECTION OF RETIRING DIRECTORANDFURTHER SUPPLEMENTAL NOTICE OF ADJOURNED ANNUAL GENERAL MEETING
TOT BIOPHARM-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
TOT BIOPHARM-B: NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED SHAREHOLDERS
TOT BIOPHARM-B: NOTIFICATION LETTER AND REQUEST FORM FOR REGISTERED SHAREHOLDERS
TOT BIOPHARM-B: SECOND FORM OF PROXY
TOT BIOPHARM-B: SUPPLEMENTAL NOTICE OF ANNUAL GENERAL MEETING
TOT BIOPHARM-B: PROPOSED ADOPTION OFTHE 2024 RESTRICTED SHARE AWARD SCHEMEANDSUPPLEMENTAL NOTICE OF ANNUAL GENERAL MEETING
TOT BIOPHARM-B: PROPOSED ADOPTION OF THE 2024 RESTRICTED SHARE AWARD SCHEME
TOT BIOPHARM-B: NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED SHAREHOLDERS
TOT BIOPHARM-B: NOTIFICATION LETTER AND REQUEST FORM FOR REGISTERED SHAREHOLDERS
TOT BIOPHARM-B: FORM OF PROXY
TOT BIOPHARM-B: NOTICE OF ANNUAL GENERAL MEETING
TOT BIOPHARM-B: PROPOSALS FORGENERAL MANDATES TO ISSUE AND BUY BACK SHARES,RE-ELECTION OF RETIRING DIRECTORS,ANDNOTICE OF ANNUAL GENERAL MEETING
TOT BIOPHARM-B: CERTAIN UNAUDITED FINANCIAL INFORMATIONFOR THE THREE MONTHS ENDED 31 MARCH 2024
No Data